Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Kohlhammer, M. Schwartz, T. Schaberg, H. Raspe, T. Schaefer (Luebeck, Rotenburg/Wuemme, Germany). Determinants of vaccination in patients with community acquired pneumonia (CAP) or chronic lung diseases. Eur Respir J 2004; 24: Suppl. 48, 181

Member's Comments

No comment yet.

Related content which might interest you: Cardiac diseases in patients with community acquired pneumonia (CAP) Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Risk factors of treatment failure of community acquired pneumonia in patients with COPD Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008 Mortality in patients with COPD due to community acquired pneumonia Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia Year: 2007 Biomarkers and community acquired pneumonia (CAP) severity Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Biomarkers and community acquired pneumonia (CAP) severity Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010 Health care associated pneumonia (HCAP) and community acquired pneumonia (CAP): Are they different diseases? Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010 Prevalence of hyponatremia (HN) in children with community acquired pneumonia (CAP) and its relation to disease severity, outcomes Source: Virtual Congress 2021 – Acute paediatric respiratory infections Year: 2021 Initial and persistent inflammatory response in treatment failure in community-acquired pneumonia Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007 Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 The relevance of chronic obstructive pulmonary disease on mortality in patients with community acquired pneumonia Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Influence of chronic cardiovascular diseases (CVD) on course and outcome of community-acquired pneumonia (CAP) Source: International Congress 2017 – The acute patient: the clinical point-of-view Year: 2017 Impact of bacterial infections on airway diseases Source: Eur Respir Rev 2005; 14: 62-68 Year: 2005 Improving outcome in elderly patients with pneumonia Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI Year: 2005 Characterization of community acquired pneumonia (CAP) with severe sepsis at diagnosis Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Health care associated pneumonia versus community acquired pneumonia: Comparison of etiology, treatment and prognosis Source: Annual Congress 2012 - Viral infections and rare respiratory infections Year: 2012 Biological markers in hospitalised patients with community acquired pneumonia (CAP) Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010 Enhanced neutrophil response in patients with chronic bronchitis and community-acquired pneumonia (CAP) Source: Eur Respir J 2002; 20: Suppl. 38, 418s Year: 2002 Results of vaccination against pneumococcal infection in patients with chronic lung diseases Source: International Congress 2019 – Airway infection in COPD Year: 2019 An outbreak of pneumococcal-chlamydial pneumonia and acute respiratory disease (ARD) among trainees Source: Eur Respir J 2001; 18: Suppl. 33, 464s Year: 2001 Treatment and prevention of acute respiratory viral infections in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Viral infections Year: 2013